Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (431-440 of 933) with videos related to

Pageof 94
Sort By:
Journal of Cellular and Molecular Medicine|October 4, 2018
Generation and characterization of hepatocellular carcinoma cell lines with enhanced cancer stem cell potentialJulienne K Muenzner, Philipp Kunze, Pablo Lindner, et al.
The Journal of Molecular Diagnostics : JMD|October 21, 2005
Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytologyMatthias Woenckhaus, Ulrike Grepmeier, Bernhard Werner, et al.
Virchows Archiv : an International Journal of Pathology|January 15, 2018
Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreeningLisa Siegler, Ramona Erber, Stefanie Burghaus, et al.
FEBS Letters|August 2, 2008
Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin releaseJohanna Weigert, Markus Neumeier, Sabrina Bauer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 19, 2013
ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic originAbbas Agaimy, Katharina Erlenbach-Wünsch, Björn Konukiewitz, et al.
The Journal of Molecular Diagnostics : JMD|April 5, 2026
Oncogenicity Variant Interpreter (OncoVI): oncogenicity guidelines implementation to support somatic variants interpretation in precision oncologyMaria Giulia Carta, Lars Tögel, Annett Hölsken, et al.
Journal of Cancer Research and Clinical Oncology|March 4, 2015
Functional analyses and prognostic significance of SFRP1 expression in bladder cancerAnja Rogler, Emil Kendziorra, Johannes Giedl, et al.
Journal of Clinical Pathology|December 2, 2011
Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of VaterSalvatore Piscuoglio, Frank S Lehmann, Inti Zlobec, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|May 23, 2015
Frequency of TERT Promoter Mutations in Prostate CancerRobert Stoehr, Helge Taubert, Ulrike Zinnall, et al.
Der Pathologe|February 24, 2021
[Practical aspects of COVID-19 autopsies]Peter Boor, Philip Eichhorn, Arndt Hartmann, et al.
Pageof 94

Showing results (431-440 of 933) with videos related to

Sort By:
Pageof 94
Journal of Cellular and Molecular Medicine|October 4, 2018
Generation and characterization of hepatocellular carcinoma cell lines with enhanced cancer stem cell potentialJulienne K Muenzner, Philipp Kunze, Pablo Lindner, et al.
The Journal of Molecular Diagnostics : JMD|October 21, 2005
Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytologyMatthias Woenckhaus, Ulrike Grepmeier, Bernhard Werner, et al.
Virchows Archiv : an International Journal of Pathology|January 15, 2018
Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreeningLisa Siegler, Ramona Erber, Stefanie Burghaus, et al.
FEBS Letters|August 2, 2008
Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin releaseJohanna Weigert, Markus Neumeier, Sabrina Bauer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 19, 2013
ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic originAbbas Agaimy, Katharina Erlenbach-Wünsch, Björn Konukiewitz, et al.
The Journal of Molecular Diagnostics : JMD|April 5, 2026
Oncogenicity Variant Interpreter (OncoVI): oncogenicity guidelines implementation to support somatic variants interpretation in precision oncologyMaria Giulia Carta, Lars Tögel, Annett Hölsken, et al.
Journal of Cancer Research and Clinical Oncology|March 4, 2015
Functional analyses and prognostic significance of SFRP1 expression in bladder cancerAnja Rogler, Emil Kendziorra, Johannes Giedl, et al.
Journal of Clinical Pathology|December 2, 2011
Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of VaterSalvatore Piscuoglio, Frank S Lehmann, Inti Zlobec, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|May 23, 2015
Frequency of TERT Promoter Mutations in Prostate CancerRobert Stoehr, Helge Taubert, Ulrike Zinnall, et al.
Der Pathologe|February 24, 2021
[Practical aspects of COVID-19 autopsies]Peter Boor, Philip Eichhorn, Arndt Hartmann, et al.
Pageof 94